Straumann stock heads into the open after a 1.9 percent gain
Published on 09/21/2026 at 07:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Straumann stock closed at EUR 149.80 on the SIX Swiss Exchange on September 18, 2026, gaining 1.9% compared with the previous session. The shares finished the day near the top of their intraday range, while the Swiss Market Index moved less strongly over the same session.
September 18, 2026 in numbers
Straumann Holding AG (ISIN CH0012280076) ended the last completed session on September 18, 2026 at EUR 149.80 on the SIX Swiss Exchange after a 1.9% advance from the prior close, according to exchange data. During the day the stock traded between an intraday low of EUR 147.20 and an intraday high of EUR 150.40, so the close came clearly above the low and only slightly below the high of the session. Trading volume on September 18, 2026 was moderate compared with recent days, indicating steady interest without an extreme shift in positioning. Versus its current 52-week range, Straumann shares remained in the upper portion of the band, with the September 18, 2026 close closer to the 52-week high than to the 52-week low.
On the same date, the Swiss Market Index also advanced, but by a smaller percentage move than Straumann, so the company outperformed its home benchmark in the last completed session. The relatively narrow intraday range from EUR 147.20 to EUR 150.40 combined with the positive close suggests a firm tone into today’s trading without a sharp spike in volatility. No major company-specific announcement or analyst rating change was published during the September 18, 2026 session that clearly redirected the share price; instead, Straumann participated in the broader positive trend across European equities.
Today’s focus for Straumann
Looking at today, September 21, 2026, there is no scheduled Straumann-specific event such as an earnings release, annual meeting or ex-dividend date that is due within the trading day based on recent public calendars. The next formal reporting date for Straumann has not been set for today in investor relations disclosures, so attention is likely to remain on sector news and macroeconomic data that can influence healthcare and medtech valuations. Broader market developments, including movements in European and US equity indices and any changes in interest rate expectations, can affect Straumann’s shares today given their sensitivity to overall risk appetite. Investors also monitor peer performance in the dental and medical technology space over the coming sessions for additional context on Straumann’s relative positioning.
